The study will investigate 27 hour profiles of hormones in the subcutaneous tissue of healthy subjects and patients with Addison's, Congenital Adrenal Hyperplasia, Growth Hormone Deficiency, acromegaly, Cushings and Primary Hyperaldosteronism during conventional diagnostic and therapeutic follow-up. The 27 hour monitoring by ULTRADIAN takes into account the rhythm of hormones throughout the day. It is hoped that this information may in the future improve and simplify diagnostic procedures. Follow-up of patients in endocrinology still remains difficult including clinical signs of over and under-treatment, questionnaires of quality of life and blood testing necessitating often retesting. Simplification of the diagnostic procedure by obtaining detailed knowledge about the rhythm of hormones may contribute to the improvement and individualization of treatment and may decrease morbidity and mortality of endocrine patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
steroids
Timeframe: 27 hours
androgens
Timeframe: 27 hours
mineralocorticoids
Timeframe: 27 hours
ACTH
Timeframe: 27 hours
growth hormone
Timeframe: 27 hours
steroids in Addison disease
Timeframe: 27 hours
steroids in congenital adrenal hyperplasia
Timeframe: 27 hours
androgen in congenital adrenal hyperplasia
Timeframe: 27 hours
growth hormone in acromegaly
Timeframe: 27 hours
growth hormone in growth hormone deficiency
Timeframe: 27 hours
mineralocorticoids in primary hyperaldosteronism
Timeframe: 27 hours